Pathophysiology and Pathomorphology of Osteoporosis

被引:16
作者
Beil, F. Timo [1 ]
Seitz, Sebastian [1 ]
Priemel, Mathias [1 ]
Barvencik, Florian [1 ]
von Domarus, Christoph [1 ]
Rueger, Johannes M. [1 ]
Amling, Michael [1 ]
Pogoda, Pia [1 ]
机构
[1] Univ Med Ctr Hamburg Eppenclorf, Dept Trauma Hand & Reconstruct Surg, Ctr Biomech & Skeletal Biol, D-20246 Hamburg, Germany
关键词
Microcallus; Osteoblast; Osteoclast; Osteoporosis; Remodeling;
D O I
10.1007/s00068-008-8201-y
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Osteoporosis is a disease that leads to fragility fractures due to the loss of bone mass and bone microstructure. This review presents an update on the fundamental pathophysiological and pathomorphological mechanisms of bone loss. Pathomorphological characteristics such as perforations and microcallus formations are explained. The physiological relevance of the remodeling process and its control by local paracrine, systemic endocrine, and central neural signaling pathways are discussed. Hormones, such as estrogen, follicle stimulating hormone, and leptin, transcription factors, such as Runx2 and osterix, and the wnt signaling pathway are discussed in terms of their roles in bone cell differentiation and function. On the basis of current knowledge, osteoporosis can be diagnosed and treated and fractures can be prevented. However, it is likely that new and even more effective diagnostic and therapeutic strategies will emerge as our understanding of the remodeling process that controls osteoblast and osteoclast function increases.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 59 条
[51]  
Sudeck P., 1900, ARCH KLIN CHIR, V62, P147
[52]   FSH directly regulates bone mass [J].
Sun, L ;
Peng, Y ;
Sharrow, AC ;
Iqbal, J ;
Zhang, Z ;
Papachristou, DJ ;
Zaidi, S ;
Zhu, LL ;
Yaroslavskiy, BB ;
Zhou, H ;
Zallone, A ;
Sairam, MR ;
Kumar, TR ;
Bo, W ;
Braun, J ;
Cardoso-Landa, L ;
Schaffler, MB ;
Moonga, BS ;
Blair, HC ;
Zaidi, M .
CELL, 2006, 125 (02) :247-260
[53]   Leptin regulates bone formation via the sympathetic nervous system [J].
Takeda, S ;
Elefteriou, F ;
Levasseur, R ;
Liu, XY ;
Zhao, LP ;
Parker, KL ;
Armstrong, D ;
Ducy, P ;
Karsenty, G .
CELL, 2002, 111 (03) :305-317
[54]   Bone resorption by osteoclasts [J].
Teitelbaum, SL .
SCIENCE, 2000, 289 (5484) :1504-1508
[55]   Influence of brain injury on early posttraumatic bone metabolism [J].
Trentz, OA ;
Handschin, AE ;
Bestmann, L ;
Hoerstrup, SP ;
Trentz, OL ;
Platz, A .
CRITICAL CARE MEDICINE, 2005, 33 (02) :399-406
[56]   Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density [J].
Van Wesenbeeck, L ;
Cleiren, E ;
Gram, J ;
Beals, RK ;
Bénichou, O ;
Scopelliti, D ;
Key, L ;
Renton, T ;
Bartels, C ;
Gong, YQ ;
Warman, ML ;
de Vernejoul, MC ;
Bollerslev, J ;
Van Hul, W .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (03) :763-771
[57]   T cell activation induces human osteoclast formation via receptor activator of nuclear factor κB ligand-dependent and -independent mechanisms [J].
Weitzmann, MN ;
Cenci, S ;
Rifas, L ;
Haug, J ;
Dipersio, J ;
Pacifici, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :328-337
[58]   Female estrogen receptor β-/- mice are partially protected against age-related trabecular bone loss [J].
Windahl, SH ;
Hollberg, K ;
Vidal, O ;
Gustafsson, JÅ ;
Ohlsson, C ;
Andersson, G .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (08) :1388-1398
[59]   Osteoclast differentiation factor is a ligand for osteoprotegerin osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL [J].
Yasuda, H ;
Shima, N ;
Nakagawa, N ;
Yamaguchi, K ;
Kinosaki, M ;
Mochizuki, S ;
Tomoyasu, A ;
Yano, K ;
Goto, M ;
Murakami, A ;
Tsuda, E ;
Morinaga, T ;
Higashio, K ;
Udagawa, N ;
Takahashi, N ;
Suda, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) :3597-3602